Hyderabad is rapidly emerging as a strategic hub for multinational companies (MNCs) deepening their focus on artificial intelligence (AI), life sciences, and global capability centres (GCCs), supported by the city's strong pharmaceutical (pharma) base, deeptech talent pool, and a policy environment that encourages high-value investment.
Union Minister Jitendra Singh inaugurated a new biotechnology facility and dedicated a national facility for recombinant cells and sensors at the Rajiv Gandhi Centre for Biotechnology in Thiruvananthapuram, highlighting India's focus on biotechnology and its potential for economic growth.
Findings of the first in-depth analysis of clinical and genomic characteristics of the Clade Ib strain, published in the journal Virology, showed seven of the 10 individuals had a history of travel to the United Arab Emirates (UAE).
India's diagnostics sector is accelerating capacity addition and geographic expansion, as large chains and regional players invest in new laboratories, integrated centres and dense sample collection networks to tap rising demand for preventive, advanced and precision testing.
There is a decisive shift in how cancer may soon be confronted and, hopefully, defeated.
The Delhi government's directive banning sending of genetic samples outside the city for advanced prenatal tests has hit opposition, with diagnostic players in the capital citing operational difficulties in complying with the order. This comes after the Annual Report on Registration of Births and Deaths in Delhi 2024 indicated that the city's sex ratio at birth (SRB) had dropped to 920 girls per 1,000 boys in 2024, down from 922 in 2023.
Breakthroughs in Artificial Intelligence and allied deep technologies are boosting productivity, efficiency and human potential to unimaginable levels, Reliance Industries chairman Mukesh Ambani said on Friday describing the "miraculous power" of AI as new 'kamdhenu', the divine wish-fulfilling cow.
If the Indian government is indeed serious about reversing brain drain, it needs to put much more emphasis on research and innovation, especially in areas that will determine the future, asserts Prosenjit Datta.
Delhi-based pharma major Mankind Pharma on Wednesday announced a collaboration with OpenAI to institutionalise artificial intelligence (AI) across its value chain, making it one of the first few Indian pharmaceutical companies to fully integrate advanced AI into its core operations.
The varieties will take at least 4 to 5 years to reach farmers after they complete the usual cycle of breeder, foundation and certified seeds.
The $1.2 billion in-space manufacturing market is expected to grow and be worth more than $20 billion by 2033.
From tackling visa woes to admission counselling, rediffGURU Dr Karan Gupta helps you choose the right course and country to study abroad.
Due to the rising COVID cases, the Centre is conducting mock drills to check facility-level preparedness and has instructed all states to ensure availability of oxygen, isolation beds, ventilators, and essential medicines, official sources had said.
India's active Covid case tally crossed the 5,000 mark with Kerala remaining the most affected state followed by Gujarat, West Bengal and Delhi, according to the Union health ministry data released on Friday.
There are 4,026 active cases in India and five fresh deaths have been reported in the last 24 hours.
Murmu said in the Indian culture, the presence of God is seen in all creatures. "The belief that our Gods and sages communicated with animals is also based on the same philosophy," she said.
Oil-to-telecom conglomerate Reliance Industries Ltd will invest Rs 75,000 crore in North Eastern states in setting up 350 biogas plants, expanding its telecom services, retail footprint, and clean energy projects, chairman Mukesh Ambani said on Friday. Speaking at the Rising NorthEast Investors Summit here, Reliance Industries Ltd chairman and managing director said his group will invest in factories for high-quality FMCG products in the region and setting up a 150-bed cancer hospital in Manipur.
All states have been instructed to ensure availability of oxygen, isolation beds, ventilators and essential medicines in view of rising cases of Covid, official sources said on Wednesday.
As of May 2025, the World Health Organization (WHO) classifies LF.7 and NB.1.8 subvariants as Variants Under Monitoring, not as Variants of Concern or Variants of Interest. But these are the variants that are reportedly driving the rise in Covid cases in China and parts of Asia.
'At Keeladi, we have not come across any evidence for organised religion.'
Amid an uptick in Covid cases in some parts of the country, Director General of the Indian Council of Medical Research (ICMR) Dr Rajiv Behl said the severity of infections as of now is generally mild and there was no cause for worry. Speaking about new Covid variants being traced, he said genome sequencing of samples in the west and south have shown that the new variants are not severe and are Omicron sub-variants. These are LF.7, XFG, JN.1 and NB. 1.8.1. The first three are more prevalent, Dr Behl said. "Samples from other places are being sequenced and we will know in a day or two if there are more variants." The ICMR DG said there has been an uptick in cases --first from the south, then west and now from northern India. All these cases are being monitored through the Integrated Disease Surveillance Programme (IDSP). Besides that, ICMR's nationwide respiratory virus sentinel surveillance network is keeping a watch on emerging infections and pathogens, he said. "Whenever cases increase, we look at three things. It's dependent on three factors with the first being how transmissible it is, conversely how fast the cases are increasing. Previously we saw Covid cases double in two days, but this time it is not that cases are increasing rapidly. "Secondly, are the new variants evading our previous immunity? When new variants come, they evade immunity -- be it natural or from the vaccine. But there's nothing to worry about at the moment," Dr Behl said. He also said that the third factor is the percentage of severe cases in all Covid instances. "Are we getting a very severe disease without comorbidities? As of now, the severity is generally low. There's nothing to worry about. We should be vigilant and we should always be prepared," the ICMR DG asserted. Dr Behl also informed reporters that the Union Health secretary chaired a meeting on Sunday that was also attended by the director general of health services and himself. "We have been closely monitoring the situation. We should be vigilant at this moment, but there is no cause to worry. The general public should be vigilant. There is no need to take any such action as of now," he said. The officer added that the WHO database has been showing that the new variants were not causing severe disease. "People do not need to take any immediate action. They should follow normal precautions. So, there is nothing special to do right now." Asked about the need for a booster dose, he said there is no need for vaccination as of now. "India has the capability to make vaccines and if need be, we can make any vaccine in no time."
Delhi Chief Minister Rekha Gupta said there is no need to panic about COVID-19 cases, even as she asserted that the hospitals were fully prepared to tackle if the number rises.
Covid is growing milder with time but an occasional surge in cases is expected because the virus that causes it is now endemic and constantly evolving, say scientists while assuring that there is no cause for concern.
It's expected that INSACOG will be once again releasing a bulletin from next week on updates about the types of variants present in India.
The Delhi high court on Tuesday said that in case there were no guidelines issued by the Centre, it expected the city government to expeditiously consider the issue of early re-testing of international travellers who test positive for COVID-19 on arrival.
"The international travellers who arrived in Mumbai from the high-risk countries have been identified and the swab samples of 28 such persons have been sent for genome sequencing. Out of them, nine persons have already tested COVID-19 positive," Health minister Rajesh Tope said.
Out of the total 190 samples, 180 (94.74 per cent) were found infected with Omicron, three with the Delta variant (1.58 per cent), one with Delta (0.53 per cent) and six with other strains of coronavirus (3.16 per cent), a Brihanmumbai Municipal Corporation (BMC) release said, citing test results of the ninth round of genome sequencing in the city.
'Today, let us reaffirm our commitment to strive to realise Gandhiji's dreams. His watchwords, truth and nonviolence, will continue to remain relevant for the whole world. He also taught us that rights and duties are but the two sides of the coin - indeed, the true source of rights is duty. Today we recall his lessons in compassion too - compassion not only for our human neighbours but also for our other neighbours, namely, flora and fauna, rivers and mountains.'
AY.12, a sub-lineage of Delta which is driving fresh cases in Israel, is being seen in many states in the country but the numbers need a closer examination, INSACOG, a genome sequencing consortium, has said in its latest bulletin.
Metropolis Healthcare (MHL) has decided to acquire a 100 per cent stake in Gurgaon-based Core Diagnostics for Rs 247 crore. This is about 2.2x FY24 (financial year 2023-24) enterprise value (EV)/sales and estimated 14x FY26 EV/Ebitda for the deal.
Do we have enough trained oncologists and medical professionals in India to man these over 4,500 beds in the public sector?
A 39-year-old Chandigarh resident who had returned from South Africa a few days ago tested positive for COVID-19 on Monday and his sample will now be sent to Delhi for whole genome sequencing.
'But it is only now being detected more via a test that costs about Rs 15,000 to Rs 20,000.' 'The HMPV virus typically causes mild respiratory symptoms in most people, but can be more severe in young children, the elderly, and those with compromised immunity.'
A 38-year-old man undergoing treatment in Kerala's northern Malappuram district has been confirmed to have contracted Mpox infection, the state health department said on Wednesday.
President A P J Abdul Kalam on Thursday said that though the country had missed the opportunity of partnering the human genome project, it should become a partner in the proteomics project for gene characterisation.
A case of COVID-19 sub-variant JN. 1 has been detected in Kerala as part of an ongoing routine surveillance activity of the Indian SARS-CoV-2 Genomics Consortium (INSACOG), a senior official from the Indian Council of Medical research (ICMR) said on Saturday.
'We have got enough internal accruals, and we are able to do acquisitions on our own.'
A multinational cow genome project has been launched that is expected to benefit both \n\nhumans and agriculture
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances